Literature DB >> 17266602

Recent advances in the discovery of alpha1-adrenoceptor agonists.

Michael J Bishop1.   

Abstract

The alpha(1) adrenoceptors are three of nine well-characterized receptors that are activated by epinephrine and norepinephrine. Agonists acting at the alpha(1) adrenoceptors produce numerous physiological effects, and are used therapeutically for several indications. Many known alpha(1) adrenoceptor agonists are alpha(1A) selective, but the discovery of highly selective alpha(1B) and alpha(1D) adrenoceptor agonists has proven to be an extremely difficult goal to achieve. This review will focus on recent advances in the discovery, development and clinical utility of subtype-specific alpha(1) agonists as well as contributions to our understanding of agonist-receptor interactions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266602     DOI: 10.2174/156802607779318217

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  2 in total

1.  An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity.

Authors:  JuYoun Beak; Wei Huang; Joel S Parker; Sean T Hicks; Cam Patterson; Paul C Simpson; Anqi Ma; Jian Jin; Brian C Jensen
Journal:  JACC Basic Transl Sci       Date:  2017-02

Review 2.  Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure.

Authors:  Dianne M Perez
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.